SLC22A12 and hyperuricemia: Therefore, this study aimed to evaluate whether COE and its major constituents (MO and LO) promote uric acid excretion by modulating URAT1 and to assess their protective effects against hyperuricemia-induced renal dysfunction and histopathological damage.